Safety Study of a Recombinant Human Plasminogen Activator to Treat Acute Ischemic Stroke.


Phase 1/2 Results



  • Hu HH, Teng MM, Hsu LC, Wong WJ, Wang LM, Luk YO, Chern CM, Soong BW, Sheng WY. A pilot study of a new thrombolytic agent for acute ischemic stroke in Taiwan within a five-hour window. Stroke. 2006 Mar;37(3):918-9. Epub 2006 Jan 19. Pubmed ID:16424373

Sources for Trial Information